Related references
Note: Only part of the references are listed.Cardamonin induces G2/M arrest and apoptosis via activation of the JNK-FOXO3a pathway in breast cancer cells
Weiwei Kong et al.
CELL BIOLOGY INTERNATIONAL (2020)
Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2
Jesus Garcia-Cano et al.
MOLECULAR ONCOLOGY (2020)
Carfilzomib inhibits the growth of lung adenocarcinoma via upregulation of Gadd45a expression
Fang Yang et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2020)
Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer
Ji Yan et al.
CELL DEATH & DISEASE (2020)
Paradoxical effects of cellular senescence-inhibited gene involved in hepatocellular carcinoma migration and proliferation by ERK pathway and mesenchymal-like markers
Qian Cheng et al.
ONCOTARGETS AND THERAPY (2019)
Oral idasanutlin in patients with polycythemia vera
John Mascarenhas et al.
BLOOD (2019)
Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment
Amit Gupta et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Inhibiting transcription in cultured metazoan cells with actinomycin D to monitor mRNA turnover
Wi S. Lai et al.
METHODS (2019)
Development and Optimization of an In Vitro Multienzyme Synthetic System for Production of Kaempferol from Naringenin
Zhiping Zhang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment
Voon Yee-Lin et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2018)
LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation
Kaixuan Zeng et al.
ONCOGENE (2018)
Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors
Andrew J. Wagner et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression
Alexis R. Barr et al.
NATURE COMMUNICATIONS (2017)
Rap2b siRNA significantly enhances the anticancer therapeutic efficacy of adriamycin in a gold nanoshell-based drug/gene co-delivery system
Li Ding et al.
ONCOTARGET (2017)
Exploiting the p53 Pathway for Therapy
Chit Fang Cheok et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges
Shaomeng Wang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Enhanced NOLC1 promotes cell senescence and represses hepatocellular carcinoma cell proliferation by disturbing the organization of nucleolus
Fuwen Yuan et al.
AGING CELL (2017)
The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins
Eun Mi Kim et al.
CANCER RESEARCH (2017)
The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85 (2016)
Ribosomal L1 domain and lysine-rich region are essential for CSIG/RSL1D1 to regulate proliferation and senescence
Liwei Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress
Nan Xie et al.
SCIENTIFIC REPORTS (2016)
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors
Philipp Holzer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression
Qian Cheng et al.
ONCOTARGET (2015)
Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications
See-Hyoung Park et al.
ONCOTARGET (2015)
The RP-Mdm2-p53 Pathway and Tumorigenesis
Paula L. Miliani de Marval et al.
Oncotarget (2015)
The role of ubiquitin modification in the regulation of p53
Andreas K. Hock et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
SAR405838: An Optimized Inhibitor of MDM2-p53 Interaction That Induces Complete and Durable Tumor Regression
Shaomeng Wang et al.
CANCER RESEARCH (2014)
Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2-p53 Inhibitor in Clinical Development
Daqing Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Regulation of the HDM2-p53 pathway by ribosomal protein L6 in response to ribosomal stress
Dongmei Bai et al.
NUCLEIC ACIDS RESEARCH (2014)
Colorectal cancer: From prevention to personalized medicine
Gemma Binefa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Rap2b, a novel p53 target, regulates p53-mediated pro-survival function
Xinyue Zhang et al.
CELL CYCLE (2013)
Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development
Qingjie Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A Potent Small-Molecule Inhibitor of the MDM2-p53 Interaction (MI-888) Achieved Complete and Durable Tumor Regression in Mice
Yujun Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress
X. Zhou et al.
ONCOGENE (2013)
Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop
X. Zhang et al.
ONCOGENE (2013)
Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential
Lorenzo Montanaro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2012)
The Retinoblastoma Protein Selectively Represses E2F1 Targets via a TAAC DNA Element during Cellular Senescence
Tianda Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
Isabelle Ray-Coquard et al.
LANCET ONCOLOGY (2012)
Nucleolar protein CSIG is required for p33ING1 function in UV-induced apoptosis
N. Li et al.
CELL DEATH & DISEASE (2012)
Epigeneitc silencing of ribosomal RNA genes by Mybbp1a
Bertrand Chin-Ming Tan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2012)
LYG-202 inhibits the proliferation of human colorectal carcinoma HCT-116 cells through induction of G1/S cell cycle arrest and apoptosis via p53 and p21WAF1/Cip1 expression
Wei Liu et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2011)
Cooperativity within and among Pten, p53, and Rb Pathways Induces High-Grade Astrocytoma in Adult Brain
Lionel M. L. Chow et al.
CANCER CELL (2011)
Downregulation of RPL6 by siRNA Inhibits Proliferation and Cell Cycle Progression of Human Gastric Cancer Cell Lines
Qiong Wu et al.
PLOS ONE (2011)
Nucleostemin Another nucleolar Twister of the p53-MDM2 loop
Dorothy Lo et al.
CELL CYCLE (2010)
Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26
Ying Zhang et al.
NUCLEIC ACIDS RESEARCH (2010)
MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation
Wei Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2
D. P. Teufel et al.
ONCOGENE (2009)
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Nucleolus, ribosomes, and cancer
Lorenzo Montanaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Structural biology of the tumor suppressor p53
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Crosstalk Between c-Myc and Ribosome in Ribosomal Biogenesis and Cancer
Mu-Shui Dai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
D. Chen et al.
ONCOGENE (2007)
Loss of centrosome integrity induces p38-p53-p21dependent G1-S arrest
Keith Mikule et al.
NATURE CELL BIOLOGY (2007)
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
A. Saxena et al.
ONCOGENE (2006)
FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal
Han You et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
p53 ubiquitination: Mdm2 and beyond
CL Brooks et al.
MOLECULAR CELL (2006)
Role of nucleophosmin in embryonic development and tumorigenesis
S Grisendi et al.
NATURE (2005)
MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53
Z Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Inhibition of HDM2 and activation of p53 by ribosomal protein L23
A Jin et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cloning and characterization of cellular senescence-associated genes in human fibroblasts by suppression subtractive hybridization
SZ Guo et al.
EXPERIMENTAL CELL RESEARCH (2004)
Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation
KP Bhat et al.
EMBO JOURNAL (2004)
Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5
MS Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway
YP Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Nucleophosmin regulates the stability and transcriptional activity of p53
E Colombo et al.
NATURE CELL BIOLOGY (2002)
Identification of p53 sequence elements that are required for MDM2-mediated nuclear export
JJ Gu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation
MW Jackson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Requirement for p27KIP1 in retinoblastoma protein-mediated senescence
K Alexander et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
MDM2-dependent ubiquitination of nuclear and cytoplasmic P53
ZK Yu et al.
ONCOGENE (2000)
Share Paper
